nobiletin has been researched along with Anoxemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Hu, F; Wang, D; Wu, J | 1 |
| Cai, XX; Dang, QY; Gao, LF; Hu, Z; Huang, DX; Liu, J; Shan, Y; Wei, YC; Yang, Q; Yu, HL; Zhang, ML; Zhang, MY; Zhang, R; Zhang, YD; Zhao, XY; Zhu, YD | 1 |
| Gao, FJ; Hu, FY; Wang, DD; Wu, JH; Xu, P; Zhang, XJ | 1 |
| Gao, XJ; Liu, HJ; Liu, JW; Xu, HT; Zhang, JJ; Zhang, QG | 1 |
4 other study(ies) available for nobiletin and Anoxemia
| Article | Year |
|---|---|
Nobiletin Alleviates Astrocyte Activation and Oxidative Stress Induced by Hypoxia In Vitro.
Topics: Astrocytes; Cells, Cultured; Flavones; Humans; Hypoxia; Oxidative Stress | 2022 |
Nobiletin Inhibits Hypoxia-Induced Placental Damage via Modulating P53 Signaling Pathway.
Topics: Animals; Female; Flavones; Humans; Hypoxia; Ischemia; Placenta; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Suppressor Protein p53 | 2022 |
Nobiletin protects retinal ganglion cells in models of ocular hypertension in vivo and hypoxia in vitro.
Topics: Animals; Disease Models, Animal; Glaucoma; Hypoxia; Neuroprotective Agents; NF-E2-Related Factor 2; Ocular Hypertension; Rats; Retinal Ganglion Cells | 2022 |
Nobiletin inhibited hypoxia-induced epithelial-mesenchymal transition of lung cancer cells by inactivating of Notch-1 signaling and switching on miR-200b.
Topics: Antioxidants; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Flavones; Humans; Hypoxia; Lung Neoplasms; MicroRNAs; Neoplasm Invasiveness; Receptor, Notch1; Signal Transduction; Wound Healing | 2015 |